COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING

Scope & Guideline

Catalyzing Change in the World of Chemistry and Screening

Introduction

Explore the comprehensive scope of COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING through our detailed guidelines, including its aims and scope. Stay updated with trending and emerging topics, and delve into declining areas to understand shifts in academic interest. Our guidelines also showcase highly cited topics, featuring influential research making a significant impact. Additionally, discover the latest published papers and those with high citation counts, offering a snapshot of current scholarly conversations. Use these guidelines to explore COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING in depth and align your research initiatives with current academic trends.
LanguageEnglish
ISSN1386-2073
PublisherBENTHAM SCIENCE PUBL LTD
Support Open AccessNo
CountryUnited Arab Emirates
TypeJournal
Convergefrom 1998 to 2024
AbbreviationCOMB CHEM HIGH T SCR / Comb. Chem. High Throughput Screen
Frequency10 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressEXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB EMIRATES

Aims and Scopes

The journal 'Combinatorial Chemistry & High Throughput Screening' focuses on the advancement of combinatorial chemistry and high-throughput screening methodologies in drug discovery and related fields. Its aims include fostering the development of novel therapeutic agents through innovative chemical and biological techniques.
  1. Combinatorial Chemistry Techniques:
    The journal emphasizes the use of combinatorial chemistry to synthesize a diverse range of compounds, facilitating the discovery of new drugs and bioactive molecules.
  2. High-Throughput Screening:
    Focus on high-throughput screening methodologies to rapidly assess the biological activity of large compound libraries, enabling efficient identification of lead compounds.
  3. Network Pharmacology:
    Integration of network pharmacology approaches to elucidate the mechanisms of action of compounds, including their interactions within biological networks.
  4. Experimental Validation:
    Encouragement of experimental validation of findings from combinatorial and high-throughput screening studies, ensuring that theoretical predictions are supported by empirical data.
  5. Natural Product Research:
    Investigation of natural products and their derivatives as potential therapeutic agents, leveraging traditional knowledge and modern analytical techniques.
The journal has seen a rise in certain themes reflecting the evolving landscape of pharmaceutical research. These emerging scopes indicate where the focus is shifting within the field.
  1. Integrative Multi-Omics Approaches:
    There is a growing trend towards using integrative multi-omics approaches, combining genomics, proteomics, and metabolomics to provide comprehensive insights into drug mechanisms and biological effects.
  2. Artificial Intelligence in Drug Discovery:
    The incorporation of artificial intelligence and machine learning techniques for predicting drug interactions, optimizing compounds, and analyzing biological data is rapidly gaining traction.
  3. Bioinformatics and Computational Modeling:
    An increase in studies utilizing bioinformatics tools and computational modeling to predict drug activity and interactions, reflecting a shift towards data-driven research.
  4. Ethnopharmacology and Natural Products:
    Revitalized interest in ethnopharmacology and the exploration of natural products as therapeutic agents, focusing on their bioactive compounds and mechanisms of action.
  5. Targeted Therapies and Personalized Medicine:
    Growing focus on targeted therapies and personalized medicine approaches, highlighting the importance of tailored treatments based on individual patient profiles.

Declining or Waning

While certain areas remain strong, there are emerging trends that suggest a decline in others within the journal's scope. The following themes show waning interest or publication frequency.
  1. Traditional Medicinal Practices:
    Research focused on traditional medicinal practices and their integration with modern pharmacological approaches appears to be declining, as the journal shifts towards more contemporary methodologies.
  2. Single-target Drug Discovery:
    There is a noticeable decrease in studies solely focusing on single-target drug discovery, as the field increasingly recognizes the complexity of biological systems and the need for multi-target approaches.
  3. Basic Pharmacology Studies:
    Basic pharmacology studies without a clear connection to combinatorial chemistry or high-throughput screening seem to be less prevalent, reflecting a shift towards more applied research.
  4. In vitro Studies without Integration:
    Research that does not integrate in vitro findings with computational or network pharmacology approaches is becoming less common, as the field moves towards more holistic methodologies.

Similar Journals

Journal of Natural Medicines

Charting New Territories in Drug Discovery and Molecular Medicine
Publisher: SPRINGER JAPAN KKISSN: 1340-3443Frequency: 4 issues/year

Journal of Natural Medicines, published by SPRINGER JAPAN KK, is a leading academic journal that plays a pivotal role in the advancement of research in the fields of Complementary and Alternative Medicine, Drug Discovery, Molecular Medicine, Organic Chemistry, and Pharmaceutical Science. Established in 1994 and set to continue until 2024, this journal serves as a vital conduit for the dissemination of groundbreaking research and innovative ideas that bridge traditional medicinal knowledge and modern scientific inquiry. With its impressive ranking in Scopus—ranking #12 out of 105 in Complementary and Alternative Medicine and holding a Q1 category quartile for 2023—it stands as a reputable source for high-quality, peer-reviewed articles. The journal's commitment to excellence is further underscored by its inclusion in the Springer network, providing researchers, professionals, and students with valuable insights and the latest developments in natural medicines. Although this journal operates under a subscription model, its profound impact on these interdisciplinary fields makes it an essential resource for anyone engaged in the study or practice of natural medicinal therapies.

Fitoterapia

Illuminating the Path of Pharmacological Exploration
Publisher: ELSEVIERISSN: 0367-326XFrequency: 8 issues/year

Fitoterapia is a prestigious journal published by Elsevier that specializes in the fields of drug discovery and pharmacology. Established in 1948 and featuring a comprehensive scope that encompasses all aspects of medicinal plants and their derivatives, this journal is a critical resource for researchers, professionals, and students interested in the pharmacological effects of natural products. With an impressive impact factor reflected in its Q2 ranking in both Drug Discovery and Medicine as well as a Q3 ranking in Pharmacology, Fitoterapia plays a vital role in promoting innovative research in the intersection of traditional medicine and modern pharmacological science. The journal’s commitment to quality is further highlighted by its rankings in Scopus, where it holds a notable position among peers in its field. Although Fitoterapia does not currently offer Open Access, its reputation for rigor and relevance makes it an indispensable asset for anyone engaged in herbal medicine research and development. Authors and researchers seeking to publish groundbreaking findings will find a welcoming platform to disseminate their work in this influential journal.

Records of Natural Products

Exploring the Essence of Nature's Pharmacy
Publisher: ACG PUBLICATIONSISSN: 1307-6167Frequency: 6 issues/year

Records of Natural Products is a distinguished journal focused on the dynamic fields of Drug Discovery, Organic Chemistry, Pharmacology, and Plant Science. Published by ACG PUBLICATIONS in Turkey, this journal serves as a vital platform for disseminating innovative research findings and advancements in natural product studies. With its convergence spanning from 2009 to 2024, Records of Natural Products holds a commendable position in the academic realm, featuring a 2023 Q3 ranking in Drug Discovery and Organic Chemistry, alongside a notable Q2 ranking in Plant Science. Despite its current lack of open access, the journal is committed to providing quality content that enriches the understanding of natural products and their potential applications. Researchers and professionals alike can benefit from the journal's insights, which not only contribute to scientific knowledge but also facilitate advancements in pharmaceuticals and sustainable practices. By exploring the rich tapestry of natural product research, this journal underscores its importance as a leading resource for professionals dedicated to enhancing the efficacy and application of natural compounds.

NATURAL PRODUCT RESEARCH

Exploring the Essence of Nature's Compounds
Publisher: TAYLOR & FRANCIS LTDISSN: 1478-6419Frequency: 24 issues/year

NATURAL PRODUCT RESEARCH is a distinguished journal published by Taylor & Francis Ltd, dedicated to advancing the field of natural product science through the dissemination of high-quality research. Established in 2003, this journal serves as a pivotal platform for scholars in Analytical Chemistry, Biochemistry, Organic Chemistry, and Plant Science, boasting an impressive categorization including Q2 in Plant Science and Q3 in the other disciplines for 2023. With a current Scopus ranking that highlights its significance within various scientific communities, NATURAL PRODUCT RESEARCH reflects the complexities and innovations associated with natural compounds and their applications. Researchers, professionals, and students will find valuable insights and breakthroughs that contribute to the understanding of bioactive compounds and their roles in health and environmental sustainability. Access options are available, ensuring that the latest findings are accessible to a global audience. As this journal continues to publish until 2024, it remains an essential resource for those at the forefront of natural product research.

CHEMICAL & PHARMACEUTICAL BULLETIN

Innovating the future of medicine through research and insights.
Publisher: PHARMACEUTICAL SOC JAPANISSN: 0009-2363Frequency: 12 issues/year

CHEMICAL & PHARMACEUTICAL BULLETIN, published by the Pharmaceutical Society of Japan, has been a cornerstone in the fields of chemistry, drug discovery, and medicine since its inception in 1958. With an ISSN of 0009-2363, this esteemed journal offers a platform for the dissemination of innovative research and critical insights contributing to these dynamic disciplines. Housed in Tokyo, Japan, it is strategically poised to bridge the gap between chemical sciences and pharmaceutical applications. Although the journal operates under a traditional subscription model and does not currently offer open access, it maintains a solid reputation, evidenced by its Q3 category rankings in multiple relevant fields and its percentile positions in Scopus, specifically 48th in General Chemistry and 30th in Drug Discovery. Researchers, professionals, and students alike will find invaluable resources within its pages, as it diligently covers shifting paradigms and emerging methodologies critical to advancing both theoretical understanding and practical applications in the pharmaceutical realm.

Chemical Biology & Drug Design

Innovating at the crossroads of science and therapeutic applications.
Publisher: WILEYISSN: 1747-0277Frequency: 12 issues/year

Chemical Biology & Drug Design, an esteemed publication by WILEY, serves as a vital platform for the dissemination of pioneering research in the interdisciplinary fields of biochemistry, drug discovery, molecular medicine, organic chemistry, and pharmacology. With a dedicated commitment to advancing the understanding of chemical interactions and drug development, this journal not only fosters innovation but also bridges the gap between theoretical research and practical applications. It boasts an impressive impact factor and is recognized in the 2023 category quartiles as Q3 in Biochemistry and Molecular Medicine, and Q2 in Drug Discovery, Organic Chemistry, and Pharmacology, indicating its relevance and influence in these crucial areas. The journal’s rankings across various Scopus categories further solidify its position as a reputable resource for researchers, professionals, and students striving to stay at the forefront of medicinal chemistry and drug design. While primarily traditional access-based, the journal's evolving scope from 2006 to 2024 ensures an ongoing contribution to essential scientific dialogue, making it an indispensable read for those committed to advancing health sciences.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS

Advancing the frontiers of medicinal chemistry.
Publisher: PERGAMON-ELSEVIER SCIENCE LTDISSN: 0960-894XFrequency: 24 issues/year

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, published by PERGAMON-ELSEVIER SCIENCE LTD, is a leading journal in the fields of biochemistry, drug discovery, and medicinal chemistry, designed to disseminate significant advances in these disciplines. Established in 1991, the journal spans various important categories, including Organic Chemistry and Pharmaceutical Science, with its 2023 Scimago Journal Rank placing it at Q2 in Organic Chemistry and Q3 in several other relevant fields. Though not an open-access publication, it provides invaluable insights into contemporary research and innovative methodologies, appealing to researchers, professionals, and students alike. The journal's commitment to quality and relevance makes it a vital resource for those aiming to stay at the forefront of bioorganic and medicinal chemistry developments. For more information, please visit the journal's website as it remains a critical platform for scholarly exchange, particularly for those engaged in interdisciplinary research.

Advances in Pharmacological and Pharmaceutical Sciences

Advancing the Frontiers of Drug Discovery.
Publisher: HINDAWI LTDISSN: 2633-4682Frequency: 1 issue/year

Advances in Pharmacological and Pharmaceutical Sciences is a premier open-access journal published by Hindawi Ltd. based in the United Kingdom. Established in 2020, the journal swiftly garnered attention for its commitment to disseminating high-quality research in the realms of pharmacology, toxicology, and pharmaceutical sciences. It holds a commendable impact with notable quartile rankings, including Q2 in both Organic Chemistry and Pharmacology, indicating its importance within these disciplines. By embracing an open-access model, the journal ensures that research findings are widely available, promoting increased visibility and collaboration among researchers, professionals, and students globally. With an ongoing convergence of insights projected through 2024, Advances in Pharmacological and Pharmaceutical Sciences aims to address critical issues and advancements in drug development and therapeutic practices, making it an invaluable resource for those at the forefront of scientific inquiry in pharmacology and related fields.

LETTERS IN ORGANIC CHEMISTRY

Unveiling Trends in Organic Chemistry and Biochemistry
Publisher: BENTHAM SCIENCE PUBL LTDISSN: 1570-1786Frequency: 12 issues/year

LETTERS IN ORGANIC CHEMISTRY is a distinguished journal published by Bentham Science Publishers Ltd, focusing on the rapidly evolving field of organic chemistry. Established in 2005, the journal commits itself to disseminating vital research findings, reviews, and innovative methodologies that contribute to the understanding and advancement of organic chemistry and biochemistry. With an ISSN of 1570-1786 and an E-ISSN of 1875-6255, this journal enhances accessibility and visibility for authors and readers alike, albeit not adopting an open-access model. Positioned within Q4 quartile rankings for both Biochemistry and Organic Chemistry, it serves a niche audience keen on exploring emerging trends and breakthroughs in these disciplines. Its Scopus rankings further reflect its role in the global academic landscape, albeit at the beginning stages of its impact journey. Based in the United Arab Emirates, LETTERS IN ORGANIC CHEMISTRY is dedicated to fostering dialogue among researchers and practitioners, paving the way for future innovations in organic and biochemical sciences.

JOURNAL OF ASIAN NATURAL PRODUCTS RESEARCH

Uncovering Hidden Treasures of Asian Pharmacology
Publisher: TAYLOR & FRANCIS LTDISSN: 1028-6020Frequency: 12 issues/year

JOURNAL OF ASIAN NATURAL PRODUCTS RESEARCH is a prestigious publication in the field of natural products, focusing on valuable research spanning analytical chemistry, pharmacology, and complementary medicine. Published by Taylor & Francis Ltd in the United Kingdom, this journal has established itself as a key resource for academics and professionals seeking to explore advancements in drug discovery and organic chemistry. With a converged publication timeline from 1998 to 2024, the journal boasts several commendable category quartiles as of 2023, reflecting its robust standing in the research community: Q2 in Complementary and Alternative Medicine, Q3 in multiple domains including Analytical Chemistry and Organic Chemistry, and Q4 in Molecular Medicine. Although it currently does not offer open access, the journal remains a valuable compendium for empirical research and innovative studies in areas such as pharmacology and medicinal chemistry. Researchers, professionals, and students alike will find the JOURNAL OF ASIAN NATURAL PRODUCTS RESEARCH to be an essential platform for sharing groundbreaking findings and fostering collaborations that lead to significant advancements in science and health.